FDA Archives - BI Journal

Public Health, Disease Prevention & Wellness

FDA Review Reexamines NurOwn® Treatment Effectiveness Evidence

PR NewswireJuly 8, 2025July 16, 2025

by PR NewswireJuly 8, 2025July 16, 2025021

BrainStorm to Continue with Planned Phase 3b Trial and Remains Committed to Advancing Access for People Living with ALS BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer...

Healthcare Quality, Patient Safety & Policy

Nitinotes Gets FDA IDE Approval to Start U.S. Trial of EndoZip™ System

PR NewswireJune 25, 2025July 14, 2025

by PR NewswireJune 25, 2025July 14, 2025069

Advancing Minimally Invasive Obesity Treatment with Automated Suturing Technology Nitinotes, developer of the EndoZip™ System, a fully automated suturing platform for endoscopic sleeve gastroplasty (ESG),...

Digital Health, Technology & Innovation

Reperio Health Raises $14M to Expand At-Home Preventive Care

Business WireMay 21, 2025May 22, 2025

by Business WireMay 21, 2025May 22, 20250106

Company has tripled preventive care participation rates and is now expanding its AI-assisted, real-time virtual care feature nationwide. Reperio Health, the only provider of at-home...

Tag : FDA

FDA Review Reexamines NurOwn® Treatment Effectiveness Evidence

Nitinotes Gets FDA IDE Approval to Start U.S. Trial of EndoZip™ System

Reperio Health Raises $14M to Expand At-Home Preventive Care

The Leadership Development Playbook for Gen Z and...

Top Three Rewards Programs to Inspire From in...

Smart Factories in 2025: Transforming Manufacturing

Securing Data Pipelines: Trends in Telecom Cybersecurity

Cross-Industry Collaborations for Future-Ready Talent

Quick Links

Stay up to date